Image source: The Motley Fool.
Enanta Pharmaceuticals Inc (NASDAQ: ENTA)
Q1 2021 Earnings Call
Feb 8, 2021 , 4:30 p.m. ET
Operator
For further details see:
Enanta Pharmaceuticals Inc (ENTA) Q1 2021 Earnings Call TranscriptImage source: The Motley Fool.
Enanta Pharmaceuticals Inc (NASDAQ: ENTA)
Q1 2021 Earnings Call
Feb 8, 2021 , 4:30 p.m. ET
Operator
For further details see:
Enanta Pharmaceuticals Inc (ENTA) Q1 2021 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Enanta Pharmaceuticals Inc. Company Name:
ENTA Stock Symbol:
Market:
Enanta Pharmaceuticals Inc. Website:
2024-03-22 05:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Enanta Pharmaceuticals, Inc . (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for indications in virology and immunology, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product S...
Enrollment Ongoing Across Three RSV Phase 2 Studies; Anticipates Announcing Topline Data for RSVPEDs and EDP-323 Challenge Study in Q3 2024 Expanded into Immunology with New Discovery Program of Oral KIT Inhibitors for First Indication in Chronic Spontaneous Urticaria; Development Candida...